Global Next Generation Sequencing (NGS) Market Outlook Study, 2019 to 2027 - Increasing Adoption in Clinical Workflows - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 4, 2019--The “Global Next Generation Sequencing Market Analysis & Trends - Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.
The Global Next Generation Sequencing Market is poised to grow strong during the forecast period 2017 to 2027.
Some of the prominent trends that the market is witnessing include increasing adoption in clinical workflows, growing demand for high-accuracy forensic tools and increasing incidence of chronic diseases.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope.
The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.
With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants, and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
This report provides data tables, includes charts and graphs for visual analysis.
- The report provides a detailed analysis of current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments
Key Topics Covered
1 Market Outline
1.1 Research Methodology
1.2 Market Trends
1.3 Regulatory Factors
1.4 Technology Analysis
1.5 Product Analysis
1.6 Application Analysis
1.7 End User Analysis
1.8 Strategic Benchmarking
1.9 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Increasing Adoption in Clinical Workflows
3.1.2 Growing Demand for High-accuracy Forensic Tools
3.1.3 Increasing Incidence of Chronic Diseases
3.1.4 Growth Opportunities/Investment Opportunities
3.4 Industry Attractiveness
4 Next Generation Sequencing Market, By Technology
4.1 Whole Exome Sequencing
4.2 Whole Genome Sequencing
4.3 Targeted Sequencing & Resequencing
4.3.1 Deoxyribonucleic Acid (DNA)-based Targeted Sequencing & Resequencing
4.3.2 Ribonucleic Acid (RNA)-based Targeted Sequencing & Resequencing
4.4 Ion Semiconductor Sequencing
4.5 Nanopore Sequencing
4.6 Sequencing By Synthesis
4.7 Single-Molecule Real-Time Sequencing
4.8 Chromatin Immunoprecipitation (CHIP) Sequencing
4.9 Methyl Sequencing
4.10 De Novo Sequencing
4.12 Sequencing by Ligation (SBL)
4.13 Reversible Terminator Sequencing
5 Next Generation Sequencing Market, By Mode
5.1 Outsourced Data Analysis
5.2 In-house Data Analysis
6 Next Generation Sequencing Market, By Product
6.1 NGS Services
6.2 NGS Commercial Software
6.2.1 Platform OS/UI
6.2.2 Analytical software
18.104.22.168 Alignment Tools & Software
22.214.171.124 QC/Pre-processing tools
6.3.1 Integrated Workflow Instruments
6.3.2 Library Preparation Instruments
6.4 Kits & Consumables
6.4.1 Library Preparation Kits
6.4.2 Multiuse Kits
6.4.3 Target Enrichment Kits
6.4.4 Sequencing Kits
7 Next Generation Sequencing Market, By Application
7.1 Drug Discovery
7.2 Agricultural & Animal Research
7.3.1 Infectious Disease Diagnostics
7.3.2 Reproductive Health Diagnostics
7.3.3 Cancer Diagnostics
7.3.4 Other Diagnostic Applications
7.4 Clinical Investigation
7.4.1 Inherited Diseases
7.4.2 Idiopathic Diseases
7.4.3 Non-communicable/Other Diseases
7.5 Human Leukocyte Antigen (HLA) Typing/Immune System Monitoring
7.6 Agrigenomics & Forensics
7.7 Consumer Genomics
7.8 Metagenomics, Epidemiology & Drug Development
7.9 Reproductive Health
7.9.1 Preimplantation Genetic Testing (PGT)
7.9.2 Noninvasive Prenatal Testing (NIPT)
7.9.3 Single Gene Analysis
7.10 Biomarker Discovery
8 Next Generation Sequencing Market, By End User
8.1 Hospitals & Clinics
8.2 Academic Institutes & Research Centers
8.3 Pharmaceutical & Biotechnology Companies
8.4 Other End Users
9 Next Generation Sequencing Market, By Geography
9.1 North America
9.3 Asia Pacific
9.4 Middle East
9.5 Latin America
9.6 Rest of the World (RoW)
10 Key Player Activities
10.1 Acquisitions & Mergers
10.2 Agreements, Partnerships, Collaborations and Joint Ventures
10.3 Product Launch & Expansions
10.4 Other Activities
11 Leading Companies
11.1 Agilent Technologies Inc.
11.2 Eurofins Scientific
11.3 Becton, Dickinson and Company
11.5 Illumina Inc.
11.6 Macrogen Inc.
11.7 Thermo Fisher Scientific Inc.
11.8 Qiagen N.V.
11.9 Perkinelmer Inc.
11.10 11x Genomics
11.11 Oxford Nanopore Technologies Ltd.
11.12 Pacific Biosciences of California Inc.
11.13 DNASTAR Inc.
11.14 Roche Holding AG
11.15 Bio-Rad Laboratories Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ubauiu
View source version on businesswire.com:https://www.businesswire.com/news/home/20190404005575/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Molecular Diagnostics
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY RESEARCH SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 04/04/2019 11:34 AM/DISC: 04/04/2019 11:34 AM